Skip to main content

#153583

BMI-1 3 Cell Line

Cat. #153583

BMI-1 3 Cell Line

Cat. #: 153583

Sub-type: Primary

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Lung

Disease: Respiratory disease

Model: Extended Lifespan

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ian Sayers

Institute: University of Nottingham

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: BMI-1 3 Cell Line
  • Alternate name: Polycomb complex protein BMI-1, polycomb group RING finger protein 4; PCGF4; RING finger protein 51; RNF51; B cell-specific Moloney murine leukemia virus integration site 1; BMI-1; FLVI2/PCGF4; Mo-MLV; Moloney murine leukemia virus; NHBEC; Normal Human Bronchial Epithelial Cells; pLVX-BMI-1 Cell Line: COPD, ALI; airâ?‚€?‚“liquid interface
  • Research fields: Cell biology;Cell signaling and signal transduction;Drug development;Genetics
  • Tool sub type: Primary
  • Organism: Human
  • Gender: Male
  • Tissue: Lung
  • Donor: Male, 19 years old, Caucasian, non-smoker and consumed alcohol
  • Disease: Respiratory disease
  • Model: Extended Lifespan
  • Description: Primary Human bronchial epithelial cells when grown in vitro have a limited lifespan and begin to deviate both in phenotype and morphology, losing the plasticity required around passage 4 or 5, for air-liquid interface (ALI) differentiation. These Human bronchial epithelial cells expressing BMI-1 retain both viability and differentiation potential of wild-type human bronchial epithelium while importantly not demonstrating changes in cell karyotype.B lymphoma Moloney murine leukemia virus insertion region 1 homolog (BMI-1) is an oncogene which functions by regulating P16 and P19 cell cycle inhibitor genes and is also associated with erythroplakia and tongue cancer. BMI-1 is thought to repress, p16(Ink4a), a cyclin-dependent kinase inhibitor and tumor suppressor that induces cell cycle arrest at the Gap 1 phase. BMI-1 can therefore be used to delay cell senescence. The airway epithelium is a critical interface acting as a barrier to potential pathogens and extraneous particles, assisting in regulation of host defense mechanisms like the inflammatory response.
  • Production details: Passage 2 heterogeneous cells were plated in a 6-well plate at 5 x 10 4 cells per well and grown overnight. Media was replaced with 800 ul of media with 2 ug/ml of polybrene and 6.25 uL of lentivirus pLVX-BmI-1 to give >90% transfection. The plates were incubated at 37Â?‚°C for 6.5 h with gentle rocking and the media replaced after 2 hours. After 72 h, selection media containing 300 ng/mL puromycin was added and cells with antibiotic resistance after 6 days of selection were considered to...
  • Additional notes: Cells were fixed for immunostaining, histology sectioning, and scanning electron microscopy after 28 days at ALI.

Target Details

  • Target: BMI-1

Applications

  • Application notes: Donor details: Male, 19 years old, Caucasian, non-smoker and consumed alcohol. Cells were fixed for immunostaining, histology sectioning, and scanning electron microscopy after 28 days at ALI.

Handling

  • Format: Frozen
  • Growth medium: Normal human bronchial epithelial cells were grown in a growth factor-supplemented medium and differentiated at ALI in bronchial epithelial differentiation medium.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: BMI-1 5 Cell Line ; BMI-1 1 Cell Line ; BMI-1 4 Cell Line ; BMI-1 6 Cell Line ; BMI-1 2 Cell Line

References

  • Torr et al. 2016. Physiol Rep. 4(16):. PMID: 27558999.
  • Expression of polycomb protein BMI-1 maintains the plasticity of basal bronchial epithelial cells.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.